baricinix 2mg tablet coated tablet
beacon medicare limited 9/b/2, toyenbee circular road, motijheel, - baricinitib - coated tablet - baricitinib inn 2mg - baricitinib
baricinix 4 4 mg film coated tablet
deel corporation; distributor: deel corporation - baricitinib (drug product for emergency use only) - film coated tablet - 4 mg
baricinix 4 4mg film-coated tablet
dynasty pharmaceuticals - baricitinib (drug product for emergency use only) - film-coated tablet - 4mg
baricinix 4mg tablet coated tablet
beacon medicare limited 9/b/2, toyenbee circular road, motijheel, - baricitinib - coated tablet - baricitinib inn 4mg - baricitinib
golden men plaster
prime pharmaceutical sdn. bhd. - olibanum; ricini semen; resina pini; radix clematidis; myrrh; momordicae folium; menthol -
amphotericin b injection, powder, lyophilized, for solution
xgen pharmaceuticals djb, inc. - amphotericin b (unii: 7xu7a7droe) (amphotericin b - unii:7xu7a7droe) - amphotericin b 50 mg in 10 ml - amphotericin b for injection usp should be administered primarily to patients with progressive, potentially life-threatening fungal infections. this potent drug should not be used to treat noninvasive fungal infections, such as oral thrush, vaginal candidiasis and esophageal candidiasis in patients with normal neutrophil counts. amphotericin b for injection usp is specifically intended to treat potentially life-threatening fungal infections: aspergillosis, cryptococcosis (torulosis), north american blastomycosis, systemic candidiasis, coccidioido-mycosis, histoplasmosis, zygomycosis including mucormycosis due to susceptible species of the genera absidia , mucor and rhizopus , and infections due to related susceptible species of conidiobolus and basidiobolus , and sporotrichosis. amphotericin b may be useful in the treatment of american mucocutaneous leishmaniasis, but it is not the drug of choice as primary therapy. this product is contraindicated in those patients who have shown hypersensitivity to amphote
amphotericin b injection
asence pharma private limited sarabhai campus dr. vikram sarabhai marg wadi - amphotericin b - injection - amphotericin 50mg - antimycotics for systemic use: antibiotics
amphotericin b for injection, usp powder for solution
sterimax inc - amphotericin b - powder for solution - 50mg - amphotericin b 50mg - polyenes
ambisome amphotericin b (amphotericin) b 50mg powder for injection
gilead sciences pty ltd - amphotericin b, quantity: 50 mg - injection, powder for - excipient ingredients: hydrogenated soy phosphatidylcholine; sucrose; dl-alpha-tocopherol; distearoylphosphatidylglycerol; sodium succinate; cholesterol - indications: ambisome is indicated for: prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b (see clinical trials). ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum. indicated as at 8 september 2003 :ambisome is indicated for: prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b (see clinical trials). ambisome is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment. ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum.
ambisome liposomal amphotericin b 50 mg powder for concentrate for dispersion for infusion
gilead sciences ireland uc - amphotericin b - concentrate for solution for infusion - 50 milligram(s) - antibiotics; amphotericin b